Pharming PHAR Cash Flow Statement (2019-2026)

NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT
Reported Financials

Pharming Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Pharming reported cash from operations of -$7.71M and free cash flow of -$7.38M for the quarter ended Jun 2026, down 164.4% year over year. This cash flow statement covers 25 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.32M13.90M3.50M15.70M9.10M-14.60M-12.21M1.30M3.46M-3.10M-12.40M-13.67M-1.10M2.90-12.45M-10.34M-14.70M5.30-14.89M-10.34M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
5.73M3.70M
Depreciation & Amortization (CF)Dep. & Amort.
-4.41M2.06M1.95M2.19M2.90M7.56M5.63M2.74M7.70M5.28M3.21M6.15M
Share-based CompensationStock Comp.
-3.70M1.91M1.64M1.07M1.97M3.32M5.69M2.92M2.64M6.05M4.51M2.58M6.58M
Gains from Investment SecuritiesGains Investment
0.02M-0.03M-1.20M-0.90M5.10M0.02M-0.20M-16.13M-16.26M-14.72M26.15M
Asset Writedowns and ImpairmentWritedown
3.74M5.99M
Other non-cash itemsOther Non-Cash
5.27M-8.16M-2.82M-3.23M5.25M-1.25M-5.70M4.45M2.32M-6.77M9.65M-11.65M0.69M
Non-cash ItemsNon-Cash Items
-25.10M9.00M11.69M6.09M-21.75M7.83M-2.57M-8.16M9.73M17.09M18.74M10.18M15.13M
Change in Working Capital
2.89M-1.97M2.40M-5.42M-11.01M-4.56M-1.38M-10.33M7.35M-7.09M-3.71M-0.69M-17.70M
Change in ReceivablesChange Receivables
4.65M2.96M4.05M-1.46M-5.54M-7.36M31.44M-4.96M2.92M8.83M-1.77M2.36M-1.56M-8.10M1.32M
Change in InventoryChange Inventory
-0.80M-0.61M0.42M-2.30M-10.72M-0.40M25.55M-3.12M-2.13M5.75M-4.05M4.79M-7.26M
Change in Account PayablesChange Payables
-0.99M-4.01M-2.33M-1.65M3.24M8.15M-2.26M6.56M-7.07M1.03M9.99M-13.16M
Change in Accured ExpensesChange Accured Exp.
1.97M0.88M
Other Operating ActivitiesOther Ops.
0.01M0.04M0.09M-0.05M0.26M1.82M2.37M1.78M1.05M1.27M0.35M1.27M
Cash from OperationsCash from Ops.
5.51M7.06M12.62M0.61M-32.41M3.53M11.58M-20.87M9.74M9.33M11.98M10.71M-7.71M
Investing Activities
Capital ExpendituresCapex
-2.02M-1.96M-0.34M-0.21M-0.99M-0.15M2.57M-0.29M-0.37M1.46M-0.41M1.23M-0.32M
Change in Property, Plant and EquipmentChange in PP&E
2.02M1.96M0.34M0.21M0.99M0.15M-2.57M0.29M0.37M-1.46M0.41M-1.23M0.32M
Change in IntangiblesChange Intangibless
-0.34M-0.46M0.24M-0.17M0.00M-0.01M0.01M
Acquisitions
5.87M-57.48M7.74M114.95M5.87M6.13M
Net of Acquisitions & DivestmentsNet Acquisitions
-5.87M57.48M-7.74M-114.95M-5.87M-6.13M
Purchase of InvestmentsInvestments Purchased
0.40M-0.19M-7.38M-87.35M-144.55M613.92M-112.45M-109.80M506.56M-102.65M
Sale and Maturity of InvestmentsInvestments Sold
-86.45M147.84M114.50M-262.35M84.97M0.01M18.12M
Other Investing ActivitiesOther investing
0.02M-0.32M0.25M-0.02M-0.05M-0.22M-0.02M-3.05M-0.29M0.71M
Cash from Investing ActivitiesCash from Investing
-7.39M-2.57M-0.30M-0.38M-67.25M-58.23M-3.91M37.06M4.35M-9.79M26.65M-0.05M-84.84M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
104.80M-0.26M
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
104.80M-0.26M
Net Debt Issuances and RepaymentsNet Debt Issuance
-134.92M-0.01M-134.92M
Change in Capital Stock
Shares Repurchased
-134.92M
Net Shares Issued and RepurchasedNet Shares Issued
134.92M
Net Equity Issued and RepurchasedNet Equity Issued
134.92M
Other financing activitiesOther financing
0.39M0.67M0.82M0.02M-0.67M8.55M-3.79M3.46M0.02M-1.91M-5.87M1.29M-8.12M-6.87M-5.87M5.10M
Cash from Financing ActivitiesCash from Financing
-2.84M-2.38M-1.92M-2.89M-5.26M5.24M-1.02M-30.78M-1.43M-2.20M-9.48M1.04M-11.67M
Additional items
Exchange Rate EffectFX Effect
4.40M-0.65M-11.66M0.41M-0.91M0.44M-0.01M0.98M-3.06M8.00M1.24M-0.60M
Change in Cash
-4.72M-11.41M10.40M-2.66M-104.92M-49.46M-147.73M-14.59M12.66M-4.59M29.15M11.70M-104.22M
Beginning Cash Balance
6.83M6.94M
Ending Cash Balance
191.92M189.67M189.96M188.70M207.34M184.78M105.03M54.65M61.74M47.14M60.66M54.94M92.09M132.37M145.31M158.28M
Free Cash FlowFCF
7.53M9.02M12.96M0.82M-31.42M3.67M9.01M-20.57M10.11M7.87M12.39M9.48M-7.39M
Net Cash FlowNCF
-4.72M2.12M10.40M-2.66M-104.92M-49.46M6.65M-14.59M12.66M-2.66M29.15M11.70M-104.22M
Interest Paid
-2.45M
Income Taxes PaidTaxes Paid
-1.55M6.21M-0.44M-4.75M-9.12M29.45M-4.32M10.07M-6.40M

Pharming Cash Flow Statement API

Pull Pharming's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PHAR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY